|
|
|
Insider
Information: |
Mason Michael |
Relationship: |
|
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
399,319 |
|
Indirect Shares
|
276 |
|
|
Direct
Value |
$470,001 |
|
|
Indirect Value
|
$40,967 |
|
|
Total
Shares |
399,595 |
|
|
Total
Value |
$510,967 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
13
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
13
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-13.0
|
Percentage
Gain/Loss : |
0.0%
|
-619.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Alnylam Pharmaceuticals Inc |
ALNY |
VP, Finance and Treasu... |
2018-08-13 |
563 |
2018-07-10 |
276 |
Premium* |
|
Karyopharm Therapeutics Inc. |
KPTI |
|
2024-03-01 |
398,756 |
2021-02-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
56 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALNY |
Alnylam Pharmaceuticals I... |
VP, Finance and Tresurer |
|
2014-01-23 |
4 |
D |
$89.49 |
$229,094 |
D/D |
(2,560) |
5,287 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
VP, Finance and Treasurer |
|
2017-12-30 |
4 |
D |
$127.05 |
$449,503 |
D/D |
(3,538) |
4,964 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
VP, Finance and Treasurer |
|
2018-08-13 |
4 |
D |
$90.95 |
$40,837 |
D/D |
(449) |
563 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
VP, Finance and TreasurerOffic |
|
2011-02-28 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
708 |
|
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
VP, Finance & Treasurer |
|
2012-07-16 |
4 |
OE |
$9.14 |
$174,554 |
D/D |
15,295 |
14,409 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
VP, Finance and Treasurer |
|
2012-07-27 |
4 |
OE |
$10.98 |
$68,625 |
D/D |
6,250 |
14,097 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
VP, Finance and Treasurer |
|
2012-11-30 |
4 |
OE |
$7.10 |
$26,625 |
D/D |
3,750 |
11,597 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
VP, Finance and Treasurer |
|
2013-06-17 |
4 |
OE |
$9.14 |
$322,203 |
D/D |
23,625 |
14,097 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
VP, Finance and Treasurer |
|
2013-07-01 |
4 |
OE |
$21.35 |
$597,450 |
D/D |
27,000 |
22,847 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
VP, Finance & Treasurer |
|
2013-07-12 |
4 |
OE |
$31.39 |
$445,738 |
D/D |
14,200 |
22,047 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
VP, Finance and Treasurer |
|
2013-12-02 |
4 |
OE |
$7.10 |
$26,625 |
D/D |
3,750 |
11,597 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
VP, Finance and Treasurer |
|
2013-12-16 |
4 |
OE |
$9.14 |
$100,510 |
D/D |
8,000 |
15,847 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
VP, Finance and Treasurer |
|
2014-12-15 |
4 |
OE |
$7.10 |
$237,117 |
D/D |
20,625 |
22,162 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
VP, Finance and Treasurer |
|
2015-06-01 |
4 |
OE |
$10.98 |
$220,526 |
D/D |
4,791 |
4,791 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
VP, Finance and Treasurer |
|
2017-05-16 |
4 |
OE |
$7.10 |
$131,588 |
D/D |
9,375 |
9,375 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
VP, Finance and Treasurer |
|
2017-12-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,502 |
8,502 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
VP, Finance and Treasurer |
|
2018-01-04 |
4 |
OE |
$42.22 |
$2,804,911 |
D/D |
31,781 |
36,745 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
SVP, CFO & Treasurer |
|
2021-02-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,150 |
8,150 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
SVP, CFO & Treasurer |
|
2021-02-11 |
4 |
S |
$15.52 |
$44,354 |
D/D |
(2,858) |
5,292 |
0 |
% |
|
KPTI |
Karyopharm Therapeutics I... |
EVP, CFO & Treasurer |
|
2022-02-07 |
4 |
S |
$9.86 |
$38,925 |
D/D |
(3,947) |
53,308 |
0 |
% |
|
KPTI |
Karyopharm Therapeutics I... |
EVP, CFO & Treasurer |
|
2022-02-28 |
4 |
S |
$10.24 |
$24,550 |
D/D |
(2,398) |
139,110 |
0 |
% |
|
KPTI |
Karyopharm Therapeutics I... |
EVP, CFO, Treasurer |
|
2022-06-03 |
4 |
S |
$6.04 |
$3,630 |
D/D |
(601) |
138,509 |
0 |
% |
|
KPTI |
Karyopharm Therapeutics I... |
EVP, CFO & Treasurer |
|
2023-02-06 |
4 |
S |
$3.40 |
$14,079 |
D/D |
(4,141) |
164,368 |
0 |
% |
|
KPTI |
Karyopharm Therapeutics I... |
EVP, CFO & Treasurer |
|
2023-02-27 |
4 |
S |
$3.04 |
$8,509 |
D/D |
(2,802) |
161,566 |
0 |
% |
|
KPTI |
Karyopharm Therapeutics I... |
EVP, CFO & Treasurer |
|
2023-03-01 |
4 |
S |
$3.03 |
$33,942 |
D/D |
(11,205) |
245,361 |
0 |
% |
|
56 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|